Trial Site Detail

 

Drug:
BEZ235 + MEK162
Trial:
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

Massachusetts General Hospital

55 Fruit Street     
Boston , MA 02114
USA

 

Principal Investigator:
Aditya Bardia
Contact:
Rosemary Boyle 617-724-0865 rboyle1@partners.org
Activation Status of this Site:
Closed
Notes about this Site:
Massachusetts General Hospital Website:
http://www2.massgeneral.org/cancer/clinical_trials/adult/search_trials.asp

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.